Psychiatry and Neurology, Neurology · Lake Success, NY
NPI
1548247125
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1991 Marcus Avenue, Suite 110
Lake Success, NY, 11042
Phone (516) 466-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$211K
1,769 services
Medicare patients, 2024
543
Average age 77
Drug cost, 2024
$2.5M
1,627 prescriptions
Company payments, 2025
$7,305
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Richard H Blanck was code 99215 (office e&m - established), 934 times for 459 patients. In total Richard H Blanck billed 1,769 services in 14 codes, and Medicare paid $211K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-03-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 934 | 459 | $155.04 | $145K |
| 99497 Care Management/Coordination | Office | 460 | 459 | $73.44 | $34K |
| 99204 Office E&M - New | Office | 108 | 108 | $142.38 | $15K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 97 | 73 | $15.06 | $1,461 |
| 96138 Behavioral Health Services | Office | 41 | 41 | $33.47 | $1,372 |
| 96139 Behavioral Health Services | Office | 38 | 38 | $34.45 | $1,309 |
| 96132 Behavioral Health Services | Office | 35 | 35 | $116.82 | $4,089 |
| 99205 Office E&M - New | Office | 32 | 32 | $193.55 | $6,193 |
| 99214 Office E&M - Established | Office | 19 | 19 | $119.03 | $2,262 |
By year: 2022 $196K for 1,581 services; 2023 $197K for 1,586 services; 2024 $211K for 1,769 services.
Medicare prescription drug claims, 2024
In 2024, the drug Richard H Blanck prescribed most often to Medicare patients was Donepezil Hcl, with 217 prescriptions and refills. In total Richard H Blanck wrote 1,627 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 217 | 480 | 58 | $2,359 |
| Gabapentin Generic | 191 | 440 | 55 | $3,795 |
| Memantine Hcl Generic | 167 | 345 | 40 | $7,237 |
| Copaxone Glatiramer Acetate | 81 | 113 | 14 | $693K |
| Topiramate Generic | 70 | 146 | 12 | $696 |
| Dalfampridine Er Dalfampridine | 63 | 123 | 12 | $36K |
| Modafinil Generic | 52 | 52 | Under 11 | $1,728 |
| Baclofen Generic | 50 | 116 | 16 | $1,135 |
| Quetiapine Fumarate Generic | 50 | 82 | 16 | $1,023 |
| Pregabalin Generic | 46 | 64 | 11 | $3,482 |
| Glatopa Glatiramer Acetate | 40 | 51 | Under 11 | $128K |
| Vumerity Diroximel Fumarate | 36 | 36 | Under 11 | $359K |
| Aimovig Autoinjector Erenumab-Aooe | 34 | 42 | Under 11 | $30K |
| Glatiramer Acetate Generic | 31 | 31 | Under 11 | $49K |
| Tecfidera Dimethyl Fumarate | 30 | 52 | Under 11 | $471K |
Brand drugs: 277 claims; generic drugs: 1,321 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Richard H Blanck $7,305 ($7,305 in general payments such as food, travel and fees) from 37 companies. The largest payer was Biogen, Inc. with $585.
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. BIIB | 15 | $585 |
| Novartis Pharmaceuticals Corporation NVS | 59 | $565 |
| TG Therapeutics, Inc. TGTX | 10 | $526 |
| SK Life Science, Inc. | 28 | $501 |
| Amgen Inc. AMGN | 22 | $485 |
| Abbvie Inc. ABBV | 28 | $419 |
| Argenx US, Inc. ARGX | 14 | $399 |
| Pfizer Inc. PFE | 19 | $379 |
| Neurocrine BioSciences, Inc. NBIX | 13 | $368 |
| Eisai Inc. 4523.T | 9 | $355 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.